SNT 2.38% 4.1¢ syntara limited

Ann: PXS Announces Encouraging Results from Phase 1c Scar Study, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,178 Posts.
    lightbulb Created with Sketch. 551
    "We estimate that up to 50% of the excess collagen in these patients’ scars has been removed and while the length of this Phase 1c safety study was not sufficient to change the appearance of an established scar the remodelling process will be ongoing and I’m confident we would see an improvement in scarappearance and physical characteristics if we observed them for longer
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
4.1¢
Change
-0.001(2.38%)
Mkt cap ! $57.67M
Open High Low Value Volume
4.2¢ 4.2¢ 4.0¢ $13.62K 337.0K

Buyers (Bids)

No. Vol. Price($)
5 605811 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.2¢ 137678 3
View Market Depth
Last trade - 11.33am 04/11/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.